Cullinan Therapeutics, Inc. financial statements
Cullinan Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 219.88M | 10-K |
| Cash and equivalents | USD 88.33M | 10-Q |
| Total debt | USD 2.68M | EODHD |
Cullinan Therapeutics, Inc. financials on 6ix · Cullinan Therapeutics, Inc. on 6ix